Alzamend Neuro (ALZN) Short Interest Ratio & Short Volume $2.35 +0.00 (+0.17%) As of 10:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alzamend Neuro Short Interest DataAlzamend Neuro (ALZN) has a short interest of 159,800 shares, representing 5.69% of the float (the number of shares available for trading by the public). This marks a 79.55% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 681,077 shares to cover all short positions.Current Short Interest159,800 sharesPrevious Short Interest89,000 sharesChange Vs. Previous Month+79.55%Dollar Volume Sold Short$359.55 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares2,900,000 sharesFloat Size2,810,000 sharesShort Percent of Float5.69%Today's Trading Volume7,374 sharesAverage Trading Volume681,077 sharesToday's Volume Vs. Average1% Short Selling Alzamend Neuro? Sign up to receive the latest short interest report for Alzamend Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALZN Short Interest Over TimeALZN Days to Cover Over TimeALZN Percentage of Float Shorted Over Time Alzamend Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025159,800 shares $359.55 thousand +79.6%5.7%0.1 $2.25 7/15/202589,000 shares $282.13 thousand +2.3%3.2%0.1 $3.17 6/30/202587,000 shares $253.17 thousand -36.1%11.2%0.1 $2.91 6/15/2025136,100 shares $440.96 thousand -80.7%17.5%0.1 $3.24 5/31/2025705,700 shares $2.84 million +386.0%92.0%0.5 $4.03 5/15/2025145,200 shares $477.71 thousand -18.6%18.9%1.2 $3.29 4/30/2025178,300 shares $1.06 million -20.3%2.8%0.4 $5.94 4/15/2025223,800 shares $170.09 thousand -37.6%3.5%0.6 $0.76 3/31/2025358,600 shares $340.06 thousand +196.6%5.7%1 $0.95 3/15/2025120,900 shares $81.87 thousand -47.0%1.9%0.3 $0.68 Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 2/28/2025228,200 shares $187.12 thousand +332.2%4.4%0.6 $0.82 2/15/202552,800 shares $57.55 thousand -33.0%1.0%0.1 $1.09 1/31/202578,800 shares $89.44 thousand +6.1%1.5%0.6 $1.14 1/15/202574,300 shares $86.93 thousand +130.8%1.4%0.5 $1.17 12/31/202432,200 shares $37.35 thousand -48.8%0.6%0.2 $1.16 12/15/202462,900 shares $74.85 thousand -52.7%1.2%0.3 $1.19 11/30/2024132,900 shares $172.77 thousand -7.9%3.1%0.6 $1.30 11/15/2024144,300 shares $196.25 thousand -35.2%3.4%0.5 $1.36 10/31/2024222,500 shares $349.33 thousand -2.6%5.3%0.1 $1.57 10/15/2024228,400 shares $381.43 thousand +121.3%5.4%0.1 $1.67 9/30/2024103,200 shares $174.41 thousand +47.9%3.0%0.1 $1.69 9/15/202469,800 shares $134.71 thousand +2.8%2.4%0 $1.93 8/31/202467,900 shares $159.57 thousand +162.2%10.7%0 $2.35 8/15/202425,900 shares $50.76 thousand +50.6%4.1%0 $1.96 7/31/202417,200 shares $61.40 thousand +126.3%2.1%1 $3.57 7/15/20247,600 shares $28.35 thousand +153.3%1.3%0.7 $3.73 6/30/202429,900 shares $11.79 thousand -68.6%0.5%0.4 $0.39 6/15/202495,100 shares $43.22 thousand +65.7%1.8%1.2 $0.45 5/31/202457,400 shares $33.87 thousand -30.1%1.1%0.9 $0.59 5/15/202482,100 shares $50.90 thousand +264.9%1.7%1 $0.62 4/30/202422,500 shares $16.00 thousand +55.2%0.5%0.3 $0.71 4/15/202414,500 shares $10.75 thousand -68.0%0.3%0.3 $0.74 3/31/202445,300 shares $45.30 thousand -11.5%0.9%0.8 $1.00 3/15/202451,200 shares $47.62 thousand +13.0%1.0%0.9 $0.93 2/29/202445,300 shares $40.77 thousand +2.5%0.9%0.7 $0.90 2/15/202444,200 shares $39.02 thousand +4.5%0.9%0.8 $0.88 1/31/202442,300 shares $36.38 thousand -41.5%0.9%0.3 $0.86 1/15/202472,300 shares $70.45 thousand -2.8%1.9%0.5 $0.97 12/31/202374,400 shares $66.22 thousand -43.5%2.1%0.6 $0.89 12/15/2023131,700 shares $131.70 thousand -29.5%3.7%1 $1.00"I'm risking my reputation on this" (Ad)For years, uncertainty held back institutional adoption. Now that dam has burst. Our FREE Crypto Revolution book shows you exactly how to position yourself for the institutional flood that's coming.Click here to claim your FREE copy now! 11/30/2023186,900 shares $226.15 thousand +379.2%5.7%1.6 $1.21 11/15/202339,000 shares $58.50 thousand -18.2%1.2%0.4 $1.50 10/31/202347,700 shares $1.25 million -92.1%1.5%2.3 $26.26 10/15/2023602,000 shares $124.01 thousand +30.0%1.2%2.8 $0.21 9/30/2023463,200 shares $109.78 thousand +82.8%1.0%2.2 $0.24 9/15/2023253,400 shares $60.82 thousand +17.3%0.5%1.3 $0.24 8/31/2023216,000 shares $56.64 thousand -60.7%0.4%1.2 $0.26 8/15/2023549,900 shares $169.92 thousand +8.9%1.2%2.8 $0.31 7/31/2023505,200 shares $228.86 thousand +2.6%1.1%3 $0.45 7/15/2023492,500 shares $247.24 thousand +4.0%1.1%3.1 $0.50 6/30/2023473,700 shares $241.59 thousand +13.0%1.1%2.9 $0.51 6/15/2023419,400 shares $285.19 thousand -44.9%0.9%2.5 $0.68 5/31/2023761,400 shares $552.93 thousand +44.0%1.7%4.2 $0.73 5/15/2023528,600 shares $274.71 thousand -11.1%1.2%3.2 $0.52 4/30/2023594,400 shares $325.32 thousand -8.6%1.3%3.5 $0.55 4/15/2023650,500 shares $382.04 thousand +10.9%1.4%3.4 $0.59 3/31/2023586,500 shares $249.26 thousand -18.2%1.3%2.9 $0.43 3/15/2023717,000 shares $343.73 thousand -0.4%1.6%2.4 $0.48 2/28/2023719,600 shares $386.35 thousand +5.1%1.6%2.4 $0.54 2/15/2023685,000 shares $401.48 thousand -31.1%1.5%2.2 $0.59 1/31/2023994,100 shares $659.78 thousand +11.2%2.2%2.8 $0.66 1/15/2023893,700 shares $529.96 thousand -44.8%2.0%2.5 $0.59 12/30/20221,620,000 shares $915.14 thousand +3.2%4.5%4.4 $0.56 12/15/20221,570,000 shares $1.40 million -7.7%4.4%3.6 $0.89 11/30/20221,700,000 shares $1.96 million -20.6%5.8%3.3 $1.15 11/15/20222,140,000 shares $2.40 million +27.4%7.3%4 $1.12 10/31/20221,680,000 shares $1.97 million -11.1%5.4%2.9 $1.17 10/15/20221,890,000 shares $1.98 million -34.2%5.5%3.1 $1.05 9/30/20222,870,000 shares $3.42 million +221.9%8.4%4.8 $1.19 9/15/2022891,700 shares $1.11 million -33.0%2.6%1.9 $1.24 8/31/20221,330,000 shares $1.20 million +112.9%3.9%3.7 $0.91 8/15/2022624,800 shares $649.79 thousand -40.5%1.8%1.6 $1.04 7/31/20221,050,000 shares $933.56 thousand -10.3%3.4%2.9 $0.89 7/15/20221,170,000 shares $1.09 million +17.2%4.0%2.3 $0.93 6/30/2022998,700 shares $863.28 thousand -4.9%3.5%1.4 $0.86 6/15/20221,050,000 shares $888.30 thousand -37.9%3.6%1.2 $0.85 5/31/20221,690,000 shares $1.59 million +79.0%5.8%1.4 $0.94 5/15/2022943,900 shares $884.81 thousand -41.0%2.4%0.7 $0.94 4/30/20221,600,000 shares $1.63 million +28.0%4.0%1.3 $1.02 4/15/20221,250,000 shares $1.30 million +51.0%3.2%1 $1.04 3/31/2022827,900 shares $1.02 million +83.2%2.1%0.6 $1.23 3/15/2022452,000 shares $411.32 thousand -11.1%1.2%0.3 $0.91 2/28/2022508,400 shares $594.83 thousand +2.1%1.3%0.2 $1.17 2/15/2022497,900 shares $687.10 thousand -22.1%1.3%0.1 $1.38 1/31/2022638,900 shares $977.52 thousand -73.0%1.7%0.2 $1.53 1/15/20222,370,000 shares $4.24 million +13.4%5.8%0.4 $1.79 12/31/20212,090,000 shares $3.97 million -10.3%5.2%0.3 $1.90 12/15/20212,330,000 shares $6.03 million +37.9%5.8%0.3 $2.59 11/30/20211,690,000 shares $3.62 million -39.4%4.3%0.3 $2.14 11/15/20212,790,000 shares $6.39 million +335.1%7.1%0.5 $2.29"I'm risking my reputation on this" (Ad)For years, uncertainty held back institutional adoption. Now that dam has burst. Our FREE Crypto Revolution book shows you exactly how to position yourself for the institutional flood that's coming.Click here to claim your FREE copy now! 10/29/2021641,200 shares $1.37 million +1.6%1.6%0.1 $2.14 10/15/2021631,400 shares $1.51 million +126.2%1.6%0.3 $2.39 9/30/2021279,100 shares $859.63 thousand -50.5%0.7%0.1 $3.08 9/15/2021563,700 shares $1.48 million +8.3%1.5%0.3 $2.63 8/31/2021520,700 shares $1.59 million +281.2%1.4%0.2 $3.06 8/13/2021136,600 shares $475.37 thousand No Change0.4%0.1 $3.48 ALZN Short Interest - Frequently Asked Questions What is Alzamend Neuro's current short interest? Short interest is the volume of Alzamend Neuro shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 159,800 shares of ALZN short. 5.69% of Alzamend Neuro's shares are currently sold short. Learn More on Alzamend Neuro's current short interest. What is a good short interest percentage for Alzamend Neuro? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.69% of Alzamend Neuro's floating shares are currently sold short. Is Alzamend Neuro's short interest increasing or decreasing? Alzamend Neuro saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 159,800 shares, an increase of 79.6% from the previous total of 89,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alzamend Neuro's float size? Alzamend Neuro currently has issued a total of 2,900,000 shares. Some of Alzamend Neuro's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alzamend Neuro currently has a public float of 2,810,000 shares. How does Alzamend Neuro's short interest compare to its competitors? 5.69% of Alzamend Neuro's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Alzamend Neuro: Generation Bio Co. (2.15%), Dyadic International Inc. (0.37%), Biodexa Pharmaceuticals PLC Unsponsored ADR (0.49%), MIRA Pharmaceuticals, Inc. (3.01%), NanoViricides, Inc. (0.57%), Tenax Therapeutics, Inc. (9.22%), Lisata Therapeutics, Inc. (0.70%), FibroBiologics Inc. (3.47%), Natural Alternatives International, Inc. (0.52%), CASI Pharmaceuticals Inc. (0.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Alzamend Neuro stock? Short selling ALZN is an investing strategy that aims to generate trading profit from Alzamend Neuro as its price is falling. ALZN shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alzamend Neuro? A short squeeze for Alzamend Neuro occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALZN, which in turn drives the price of the stock up even further. How often is Alzamend Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALZN, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Generation Bio Short Interest Data Dyadic International Short Interest Data Biodexa Pharmaceuticals Short Interest Data MIRA Pharmaceuticals Short Interest Data NanoViricides Short Interest Data Tenax Therapeutics Short Interest Data Lisata Therapeutics Short Interest Data FibroBiologics Short Interest Data Natural Alternatives International Short Interest Data CASI Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALZN) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access